Clinical Trial: Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery

U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07326865) titled 'Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery' on Dec. 03, 2025.

Brief Summary: The goal of this clinical trial is to learn how the liver responds to sugar in people with obesity who are having bariatric surgery. Researchers want to understand differences between people with and without metabolic associated steatotic liver disease (MASLD).

The main question is:

Does giving sugar directly into the vein change how liver genes work in people with and without MASLD?

Researchers will compare:

* People with MASLD who receive sugar

* People with MASLD who receive sali...